At a glance

Bringing brilliant ideas to life

Sobi is a global biopharma company unlocking the potential​ of breakthrough innovations, transforming everyday life for​ people living with rare diseases.
 

Sobi in short:

• Global footprint with own presence in around 30 countries, delivering medicines to patients in many more
• Approximately 1,900 employees across Europe, North America, the Middle East, Asia, and Australia
• Global Head office in Stockholm, Sweden, with hubs in Basel, Switzerland and Waltham, MA (US)
• In 2024, revenue amounted to SEK 26 billion
• The Sobi share (STO:SOBI) is listed on Nasdaq Stockholm.